Plasmapheresis treatment in COVID-19-related autoimmune meningoencephalitis: Case series

Brain Behav Immun. 2020 Jul;87:155-158. doi: 10.1016/j.bbi.2020.05.022. Epub 2020 May 7.

Abstract

Severe SARS-CoV-2 (COVID-19) infection has the potential for a high mortality rate. In this paper, we report the results of plasmapheresis treatment in a series of severely ill patients with COVID-19-related autoimmune meningoencephalitis in the Intensive Care Unit (ICU).

Keywords: Autoimmune; COVID-19; Encephalitis; Plasmapheresis.

Publication types

  • Case Reports

MeSH terms

  • Autoimmune Diseases / therapy
  • Betacoronavirus / pathogenicity
  • COVID-19
  • Coronavirus Infections / complications
  • Coronavirus Infections / therapy*
  • Female
  • Humans
  • Male
  • Meningoencephalitis / complications
  • Meningoencephalitis / therapy
  • Middle Aged
  • Pandemics
  • Plasmapheresis / methods*
  • Pneumonia, Viral / complications
  • Pneumonia, Viral / therapy*
  • SARS-CoV-2